Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaker A Mousa

Showing results (41-50 of 435) with videos related to

Pageof 44
Sort By:
Acta Tropica|April 26, 2011
Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testingDavid Laurenzo, Shaker A Mousa
Pharmacology & Therapeutics|September 20, 2011
Metformin and neoplasia: implications and indicationsAhmad Aljada, Shaker A Mousa
Translational Lung Cancer Research|July 15, 2016
Non-small cell lung cancer: current treatment and future advancesCecilia Zappa, Shaker A Mousa
Clinical Ophthalmology (Auckland, N.Z.)|November 3, 2012
Current primary open-angle glaucoma treatments and future directionsGabriel Beidoe, Shaker A Mousa
Journal of Cardiovascular Pharmacology|January 18, 2005
Human alphavbeta3 integrin potency and specificity of TA138 and its DOTA conjugated form (89)Y-TA138Shaker A Mousa, Seema Mohamed
Biomedicines|June 22, 2017
The Role of Angiogenesis in Cancer TreatmentMehdi Rajabi, Shaker A Mousa
Drugs of Today (Barcelona, Spain : 1998)|January 14, 2010
Current status of nucleoside antivirals in chronic hepatitis BAnhtung Duong, Shaker A Mousa
Nanotechnology, Science and Applications|November 8, 2013
Biosensors: the new wave in cancer diagnosisBrian Bohunicky, Shaker A Mousa
Expert Review of Clinical Pharmacology|September 10, 2020
A narrative review of buprenorphine in adult cancer painMatthew Degnan, Shaker A Mousa
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 3, 2020
Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 PandemicFaisal Alsayegh, Shaker A Mousa
Pageof 44

Showing results (41-50 of 435) with videos related to

Sort By:
Pageof 44
Acta Tropica|April 26, 2011
Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testingDavid Laurenzo, Shaker A Mousa
Pharmacology & Therapeutics|September 20, 2011
Metformin and neoplasia: implications and indicationsAhmad Aljada, Shaker A Mousa
Translational Lung Cancer Research|July 15, 2016
Non-small cell lung cancer: current treatment and future advancesCecilia Zappa, Shaker A Mousa
Clinical Ophthalmology (Auckland, N.Z.)|November 3, 2012
Current primary open-angle glaucoma treatments and future directionsGabriel Beidoe, Shaker A Mousa
Journal of Cardiovascular Pharmacology|January 18, 2005
Human alphavbeta3 integrin potency and specificity of TA138 and its DOTA conjugated form (89)Y-TA138Shaker A Mousa, Seema Mohamed
Biomedicines|June 22, 2017
The Role of Angiogenesis in Cancer TreatmentMehdi Rajabi, Shaker A Mousa
Drugs of Today (Barcelona, Spain : 1998)|January 14, 2010
Current status of nucleoside antivirals in chronic hepatitis BAnhtung Duong, Shaker A Mousa
Nanotechnology, Science and Applications|November 8, 2013
Biosensors: the new wave in cancer diagnosisBrian Bohunicky, Shaker A Mousa
Expert Review of Clinical Pharmacology|September 10, 2020
A narrative review of buprenorphine in adult cancer painMatthew Degnan, Shaker A Mousa
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 3, 2020
Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 PandemicFaisal Alsayegh, Shaker A Mousa
Pageof 44